Walgreens has agreed to be taken private for $11.45 per share, approved by shareholders, with shares trading slightly above the takeover price. There’s potential for an additional payout of up to $3 per share. The company has faced challenges, including failed growth strategies and dividend cuts, leading to the decision to go private.

The takeover by Sycamore Partners Management is expected to close in the second half of 2025. Typically, shares of an acquired company trade below the takeover price, but Walgreens shares are trading slightly above, indicating a unique situation. Sycamore plans to sell Walgreens’ medical clinic business, offering shareholders a potential $3 per share payout.

Investing in Walgreens carries high risk due to uncertainties around the sale of the clinic business and potential payout timeline. Conservative investors should avoid, while aggressive investors may find the special situation appealing. The company will no longer be publicly traded after the takeover, but may eventually return to the market with different shares and a stronger industry position.

The Motley Fool Stock Advisor recommends 10 other stocks over Walgreens, citing potential for significant returns. Historical examples show substantial growth from past recommendations. The stock advisor’s average return is 1,060%, outperforming the S&P 500. Joining the Stock Advisor provides access to the latest top 10 list for potential high returns.

Read more at Yahoo Finance: Where Will Walgreens Be in 1 Year?